e-learning
resources
London 2016
Sunday, 04.09.2016
Translational studies in lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Induced sputum lipid mediators in severe asthma
Rahul Shrimanker (Bristol, United Kingdom), Rahul Shrimanker, Samantha Thulborn, Catherine Borg, Clare Connolly, Ian Pavord
Source:
International Congress 2016 – Translational studies in lung disease
Session:
Translational studies in lung disease
Session type:
Thematic Poster
Number:
926
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Rahul Shrimanker (Bristol, United Kingdom), Rahul Shrimanker, Samantha Thulborn, Catherine Borg, Clare Connolly, Ian Pavord. Induced sputum lipid mediators in severe asthma. Eur Respir J 2016; 48: Suppl. 60, 926
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Evaluation of inflammatory markers IL-6 and MMP-9 in asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Implication of IL-18 in the chronic inflammation of severe refractory asthma
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Phenotypic characteristics of asthma with small airways involvement
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Analysis of the inflammatory profile of children with controlled and uncontrolled severe asthma
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016
The first U-BIOPRED sputum handprint of severe asthma
Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey
Year: 2015
Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma
Source: Annual Congress 2013 –Genetic factors in airway development and disease
Year: 2013
Proinflammatory cytokines and IP-10 differentiate neutrophilic and eosinophilic asthma subgroups
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Induced sputum cytokines and chemokines and mechanistic pathways in adult asthma phenotypes
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Obesity influences inflammatory phenotype mainly in early onset severe asthmatics
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Induced sputum in children With persistent asthma: The effect to inhaled corticosteroid treatment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
LATE-BREAKING ABSTRACT: Sputum transcriptome analysis yields eosinophilic and non-eosinophilic inflammatory mechanisms in UBIOPRED asthma cohort
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Peripheral pathological ILC2: An inflammatory indicator for the assessment of asthma control in clinics
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016
Airway inflammation in patients with different levels of asthma control
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
Airway remodeling and eosinophilic asthma
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Expression of nasal and bronchial IL-17F and related cytokines in frequent exacerbators with neutrophilic severe asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Associated factors with persistent airflow limitation in asthma in U-BIOPRED
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept